NEW YORK - Medical device maker and diversified health care company Covidien Ltd. said Friday it completed the sale of its retail products unit to First Quality Enterprises Inc. for $330 million in cash.
| COV | 53.06 |
The sale was announced in December, but for $335 million.
The sale is part of Covidien's strategy to focus on its core health care business. Other units being sold include the company's incontinence business and the specialty chemicals unit.
Shares of Covidien fell 85 cents to $45.71 in after-hours trading after rising $1.22, or 2.7 percent, to close at $46.56 during the regular trading session.

Gold headed back to revisit Tuesday's low of $790 and then recovered once again before the close of futures trading, to climb back to just a...
Stephenie Meyer, who wrote 'Twilight', will not continue writing ...
IN THE HEADLINES McCain caps GOP convention vowing 'change is coming' to Washing...


Professional Website Design For Corporate - Get a Free Quote Today